What does DR. GLIBERT NELE NEUROLOGIE do?

DR. GLIBERT NELE NEUROLOGIE is a specialist medical practice in Izegem. Private Limited, started on 16 November 2020, 1 establishment.

What is the address of DR. GLIBERT NELE NEUROLOGIE?

The registered office of DR. GLIBERT NELE NEUROLOGIE is located at Kokelarestraat 46, 8870 Izegem.

Is DR. GLIBERT NELE NEUROLOGIE still active?

Yes. According to the CBE (30 October 2026) DR. GLIBERT NELE NEUROLOGIE is active, legal situation “Normale toestand”, started on 16 November 2020.

Is DR. GLIBERT NELE NEUROLOGIE registered on Peppol?

Yes, DR. GLIBERT NELE NEUROLOGIE is registered on the Peppol network with ID 0208:0758468833.

What is the enterprise number of DR. GLIBERT NELE NEUROLOGIE?

The enterprise number of DR. GLIBERT NELE NEUROLOGIE is BE0758468833.

When was DR. GLIBERT NELE NEUROLOGIE founded?

DR. GLIBERT NELE NEUROLOGIE was founded on 16 November 2020.

Who are the directors of DR. GLIBERT NELE NEUROLOGIE?

According to the 2025 annual accounts, the directors of DR. GLIBERT NELE NEUROLOGIE are: Nele Glibert.

Is DR. GLIBERT NELE NEUROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 November 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. GLIBERT NELE NEUROLOGIE make in 2025?

DR. GLIBERT NELE NEUROLOGIE posted a profit after taxes of € 244,701 in financial year 2025.

What is the revenue of DR. GLIBERT NELE NEUROLOGIE?

As a small company, DR. GLIBERT NELE NEUROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 354,476.

DR. GLIBERT NELE NEUROLOGIE (Private Limited) - Izegem

Dossier DR. GLIBERT NELE NEUROLOGIE, printed on 30 October 2026 from databakkes.be/en/0758468833/dr-glibert-nele-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 34 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. GLIBERT NELE NEUROLOGIE from Izegem, company number BE0758468833, closed financial year 2025 with a result of € 244,701 after tax. For that financial year DR. GLIBERT NELE NEUROLOGIE recorded a gross margin of € 354,476 and equity of € 2,000. Compared with financial year 2024, the result moved from € 214,529 to € 244,701. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 20, 2026.

What it is worth Shrank hard

€ 2,000

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 244,701

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 146,101

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 459,231 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 78

▼ 77% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 370

▲ € 352 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 40,281

▲ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 265,129 Gross margin 2022: € 265,129 First fiscal year in the series	€ 281,763 Gross margin 2023: € 281,763 ▲ 6% vs 2022 (€ 265,129) Favourable step	€ 325,460 Gross margin 2024: € 325,460 ▲ 16% vs 2023 (€ 281,763) Favourable step	€ 354,476 Gross margin 2025: € 354,476 ▲ 9% vs 2024 (€ 325,460) Favourable step	▲ 9%
Profit after taxes	€ 181,875 Profit after taxes 2022: € 181,875 First fiscal year in the series	€ 188,703 Profit after taxes 2023: € 188,703 ▲ 4% vs 2022 (€ 181,875) Favourable step	€ 214,529 Profit after taxes 2024: € 214,529 ▲ 14% vs 2023 (€ 188,703) Favourable step	€ 244,701 Profit after taxes 2025: € 244,701 ▲ 14% vs 2024 (€ 214,529) Favourable step	▲ 14%
Equity	€ 495,748 Equity 2022: € 495,748 First fiscal year in the series	€ 190,703 Equity 2023: € 190,703 ▼ 62% vs 2022 (€ 495,748) Unfavourable step	€ 216,529 Equity 2024: € 216,529 ▲ 14% vs 2023 (€ 190,703) Favourable step	€ 2,000 Equity 2025: € 2,000 ▼ 99% vs 2024 (€ 216,529) Unfavourable step	▼ 99%
Total debts	€ 81,400 Total debts 2022: € 81,400 First fiscal year in the series	€ 244,630 Total debts 2023: € 244,630 ▲ 201% vs 2022 (€ 81,400) Unfavourable step	€ 238,830 Total debts 2024: € 238,830 ▼ 2% vs 2023 (€ 244,630) Favourable step	€ 443,142 Total debts 2025: € 443,142 ▲ 86% vs 2024 (€ 238,830) Unfavourable step	▲ 86%
Cash	€ 248,897 Cash 2022: € 248,897 First fiscal year in the series	€ 101,150 Cash 2023: € 101,150 ▼ 59% vs 2022 (€ 248,897) Unfavourable step	€ 147,664 Cash 2024: € 147,664 ▲ 46% vs 2023 (€ 101,150) Favourable step	€ 146,101 Cash 2025: € 146,101 ▼ 1% vs 2024 (€ 147,664) Unfavourable step	▼ 1%
Land & buildings	€ 23,273 Land & buildings 2022: € 23,273 First fiscal year in the series	€ 49,469 Land & buildings 2023: € 49,469 ▲ 113% vs 2022 (€ 23,273) Unchanged	€ 50,235 Land & buildings 2024: € 50,235 ▲ 2% vs 2023 (€ 49,469) Unchanged	€ 45,568 Land & buildings 2025: € 45,568 ▼ 9% vs 2024 (€ 50,235) Unchanged	▼ 9%
Retained profit	€ 493,748 Retained profit 2022: € 493,748 First fiscal year in the series	€ 188,703 Retained profit 2023: € 188,703 ▼ 62% vs 2022 (€ 493,748) Unfavourable step	€ 214,529 Retained profit 2024: € 214,529 ▲ 14% vs 2023 (€ 188,703) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 214,529) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 493,748 Dividend 2023: € 493,748 Unchanged (€ 0) Unchanged	€ 188,703 Dividend 2024: € 188,703 ▼ 62% vs 2023 (€ 493,748) Unchanged	€ 459,231 Dividend 2025: € 459,231 ▲ 143% vs 2024 (€ 188,703) Unchanged	▲ 143%
Balance sheet total	€ 577,148 Balance sheet total 2022: € 577,148 First fiscal year in the series	€ 435,333 Balance sheet total 2023: € 435,333 ▼ 25% vs 2022 (€ 577,148) Unchanged	€ 455,359 Balance sheet total 2024: € 455,359 ▲ 5% vs 2023 (€ 435,333) Unchanged	€ 445,142 Balance sheet total 2025: € 445,142 ▼ 2% vs 2024 (€ 455,359) Unchanged	▼ 2%

Key figures of DR. GLIBERT NELE NEUROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. GLIBERT NELE NEUROLOGIE?

What happened at DR. GLIBERT NELE NEUROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 20, 2026 New annual accounts for financial year 2025: profit of € 244,701 (▲ 14% vs 2024). filed late Source: NBB ↗
Nov 16, 2020 New establishment in Izegem. KBO
Nov 16, 2020 Start of the company according to the CBE. KBO

In short

From € 181,875 profit in 2022 to € 244,701 profit in 2025.

Paid € 263,428 in corporate taxes since 2022.

Best year ever: 2025, with € 244,701 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nele Glibert

DR. GLIBERT NELE NEUROLOGIE

Behind DR. GLIBERT NELE NEUROLOGIE is Nele Glibert.

Directors

According to the 2025 annual accounts

Nele Glibert

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kokelarestraat 46

8870 Izegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Maneas

€ 243,995 gross margin · 2025

AHS Invest

€ 980,416 gross margin · 2025

AHS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0758.468.833

VAT number

BE 0758.468.833

Registered office

Kokelarestraat 46, 8870 Izegem

Names & denominations

DR. GLIBERT NELE NEUROLOGIE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 November 2020

Peppol

Active · Active since 2 Mar 2026

Activities · NACE

Activiteiten van medisch specialisten

Detailhandel in vaste, vloeibare en gasvormige brandstoffen, muv motorbrandstoffen

Overige detailhandel, niet in winkels en exclusief markt- en straathandel

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. GLIBERT NELE NEUROLOGIE

Warning lights

Financials

What happened to DR. GLIBERT NELE NEUROLOGIE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions